SBIR/STTR Research Award

Enabling Nanomembrane-Based Biomolecule and Nanoparticle Separations

Award identifier 291d51423a89bfae28e3d01c87bd4f62dee2e18f9e3c4c83398365e2a4ef53bfAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$198,938

Program and phase

STTR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Simpore Inc.
Proposal award date
2016-07-19
Contract end date
2018-01-18
UEI
NYNDZ3F46K36
Solicitation number
PA14-072
Topic code
400

Research abstract

DESCRIPTION provided by applicant The global market for nanoparticles NP in biotechnology drug development and drug delivery was estimated to be $ B for and is expected to reach more than $ B by The two most active areas of product development are NPs for drug delivery and for in vivo imaging In these applications it is often critical that he outer surfaces of NPs are functionalized with antibodies Ab that target them to speci c tissues After functionalizing NPs with Abs it is necessary to remove unbound Ab from the NP preparation because any free Ab will compete with the NPs for target tissues Given the similar sizes of Ab nm and NPs this ubiquitous clean up step is challenging and represents a current pain in the market place Both academic and industrial NP scientists report that existing polymer based membranes are not capable of performing this separation and that they must resort to more time consuming complex and lower yield techniques such as size exclusion chromatography or dialysis Membrane based methods are preferred because of their simplicity ef ciency and scalability In this proposal we will realize a near term straight forward produc development opportunity that will result in a solution to the NP Ab separation problem Using SiMPoreandapos s nanomembranes in a custom centrifuge con guration we have recently shown the ability to separate Ab from nm polystyrene particles Additional innovations in membrane fabrication and non fouling coatings will allow us to pursue the following goals to develop and evaluate a SiMPore product prototype based on our preliminary custom centrifuge concept to produce a suf cient number of prototypes to enable beta testing at two major life science tool suppliers and to introduce a validated product upon completion of this month Phase I project PUBLIC HEALTH RELEVANCE This proposal focuses on developing laboratory tools for removing antibodies from nano particle conjugations Antibody conjugated nano particles are useful for both research and diagnostic purposes Our tools will help increase the specificity of these preparations

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

12 SBIR/STTR records share this UEI (2010–2022). Reported award amounts total $5,643,223. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.